Wenqi Xu
- Cancer Research top 10%
-
- Cancer-related gene regulation 5
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 4
- Histone Deacetylase Inhibitors Research 3
- Genomics and Chromatin Dynamics 2
-
- HVDC Systems and Fault Protection 2
-
- Adenosine and Purinergic Signaling 1
-
- Microbial Community Ecology and Physiology 1
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wenqi Xu
10 papers receiving 732 citations
Hit Papers
Peers
Comparison fields: 5 of 63
- Cancer Research 211
- Molecular Biology 676
- Immunology 48
- Aging 3
- Genetics 43
Countries citing papers authored by Wenqi Xu
This map shows the geographic impact of Wenqi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenqi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenqi Xu more than expected).
Fields of papers citing papers by Wenqi Xu
This network shows the impact of papers produced by Wenqi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenqi Xu. The network helps show where Wenqi Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenqi Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 16 | |
| 4 | 2022 | 105 | |
| 5 | METTL3 regulates heterochromatin in mouse embryonic stem cellsbreakdown → | 2021 | 246 |
| 6 | 2020 | 23 | |
| 7 | 2017 | 40 | |
| 8 | 2017 | 6 | |
| 9 | 2016 | 33 | |
| 10 | 2016 | 132 | |
| 11 | 2012 | 130 |
About Wenqi Xu
Wenqi Xu is a scholar working on Physiology, Molecular Biology and Biochemistry, having authored 11 papers that have together received 733 indexed citations. Recurring topics across this work include Cancer-related gene regulation (5 papers), RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (4 papers), Histone Deacetylase Inhibitors Research (3 papers), HVDC Systems and Fault Protection (2 papers), Genomics and Chromatin Dynamics (2 papers), Adenosine and Purinergic Signaling (1 paper) and Microbial Community Ecology and Physiology (1 paper). The work is most often cited by research in Cancer Research (211 citations), Molecular Biology (676 citations) and Immunology (48 citations). Wenqi Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hongjie Shen, Feizhen Wu, Yujiang Geno Shi, Yang Shi, Chenxi He, Fei Lan, Honghui Ma, Bowen Rong, Wang Jia-hua and Li Tan. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.